Balaxi Pharmaceuticals Ltd share price logo

Balaxi Pharmaceuticals Ltd Share Price (BALAXI)


Get free price alerts. Set up your Free investment account to get Live Prices. >
Q3 '23 Results
News and Events

Overview of Balaxi Pharmaceuticals Ltd

Key events for Balaxi Pharmaceuticals Ltd

  • Balaxi Pharma Q3 Net Sales Down 44.95%, Quarterly Net Profit Down 86.18% - 13 Feb, 2024

    Balaxi Pharmaceuticals Ltd's net sales for Q3 December 2023 decreased by 44.95% YoY, while quarterly net profit declined by 86.18%. The EPS also decreased from Rs. 3.52 to Rs. 0.48. Balaxi Pharma shares closed at 559.90 on February 12, 2024 (NSE) and have given returns of 19.06% over the last 6 months and 8.53% over the last 12 months.

  • Balaxi Pharmaceuticals Q3 2024 Net Income Up by 65% - 11 Feb, 2024

    Balaxi Pharmaceuticals reported a net income of ₹135.9m in Q3 2024, up 65% YoY. However, revenue for the same period was down 30% YoY at ₹606.5m.

  • Balaxi Pharmaceuticals Ltd Shares Jump 38% in a Month - 10 Feb, 2024

    Despite a full-year gain of only 5.2%, Balaxi Pharmaceuticals' recent share price jump may still be sending buy signals with its P/S ratio of 2.1x, lower than the industry average. However, poor financial performance and declining revenue may be causing the reduced P/S ratio. Investors hope this isn't the case so they can pick up the stock at a lower valuation.

  • Balaxi Pharmaceuticals' Balance Sheet Shows Net Cash of ₹94.1m - 09 Feb, 2024

    Balaxi Pharmaceuticals has a healthy balance sheet with net cash of ₹94.1m and short term liquidity, but its EBIT has plunged 14% in the last twelve months.

Balaxi Pharmaceuticals Ltd share Performance

  • ₹612.5
    downward going graph



    Day's Volatility:2.83%



    downward going graph
  • ₹399.95
    downward going graph



    52 Weeks Volatility:46.38%



    downward going graph
1 Month Return40.17 %
3 Month Return46.12 %
1 Year Return15.41 %
Previous Close₹611.65
Market Cap₹625.73Cr

Balaxi Pharmaceuticals Ltd Company Information

Balaxi Ventures Limited formerly known as The Anandam Rubber Company, is a public limited company established in India since 1942. In 1989, the company sold its plantations to focus on investments and trading. The Securities and Exchange Board of India (SEBI) issued a revised Exit Policy in 2012 for derecognized/non-operational stock exchanges. Consequently, Madras Stock Exchange was derecognized by SEBI and The Anandam Rubber Company applied to list its shares with the National Stock Exchange of India (NSE) in January 2015.
In March 2017, Balaxi Overseas Pvt Ltd acquired 16,700,036 (54.94%) equity shares of the company along with its control and management. Its representatives became the new directors and the company was renamed to Balaxi Ventures. A preferential issue of 6,960,000 equity shares was approved in July 2019 and allotted in August, increasing the company’s paid-up share capital to Rs 100,000,000. Following this, Balaxi Ventures started international wholesale trading in pharmaceutical products, builders hardware, and recently launched YAP food products.

Share Price: ₹617.40 per share as on 23 Feb, 2024 04:01 PM
Market Capitalisation: ₹625.73Cr as of today
Revenue: ₹60.79Cr as on December 2023 (Q4 23)
Net Profit: ₹13.59Cr as on December 2023 (Q4 23)
Listing date: 30 Nov, 2015
OrganisationBalaxi Pharmaceuticals Ltd
E-voting on sharesClick here to vote

Fundamentals of Balaxi Pharmaceuticals Ltd

Insights on Balaxi Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.


    Revenue Rich


    Revenue is up for the last 2 quarters, 60.65 Cr → 62.29 Cr (in ₹), with an average increase of 2.6% per quarter


    Price Rise


    In the last 1 month, BALAXI stock has moved up by 40.2%

  • imgNO EFFECT

    Against Peers


    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 157.9% return, outperforming this stock by 149.5%

  • imgNO EFFECT

    Against Peers


    In the last 1 year, Sun Pharmaceuticals Industries Ltd has given 60.2% return, outperforming this stock by 44.8%

  • imgNO EFFECT

    Promoter Holding Unchanged


    Promoters holdings remained unchanged at 71.22% of holdings in Dec 2023 quarter

  • imgNO EFFECT

    Retail Holding Unchanged


    Retail Investor holdings remained unchanged at 10.18% of holdings in Dec 2023 quarter

  • imgNO EFFECT

    FII Holding Unchanged


    Foreign Institutions holdings remained unchanged at 18.57% of holdings in Dec 2023 quarter


    Profit Down


    Netprofit is down for the last 2 quarters, 14.43 Cr → 13.59 Cr (in ₹), with an average decrease of 5.8% per quarter

Balaxi Pharmaceuticals Ltd Valuation

Balaxi Pharmaceuticals Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-124.50x)

February 20, 2024

Today (-120.17x)

February 22, 2024

Industry (106.52x)

February 22, 2024

Highest (66.45x)

September 21, 2020


Balaxi Pharmaceuticals Ltd Shareholding Pattern

InvestorsHoldings %Prev. 4 periods3M change
Promoter Holdings
Foreign Institutions
Mutual Funds
Retail Investors

Technicals of Balaxi Pharmaceuticals Ltd share

News & Events of Balaxi Pharmaceuticals Ltd

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Balaxi Pharmaceuticals Ltd shares.

Balaxi Pharmaceuticals Ltd (BALAXI) share price today is ₹617.4

Balaxi Pharmaceuticals Ltd is listed on NSE

Balaxi Pharmaceuticals Ltd is not listed on BSE

  • Today’s highest price of Balaxi Pharmaceuticals Ltd is ₹630.
  • Today’s lowest price of Balaxi Pharmaceuticals Ltd is ₹612.5.

PE Ratio of Balaxi Pharmaceuticals Ltd is -120.17

PE ratio = Balaxi Pharmaceuticals Ltd Market price per share / Balaxi Pharmaceuticals Ltd Earnings per share

Today’s traded volume of Balaxi Pharmaceuticals Ltd(BALAXI) is 6,346.00.

Today’s market capitalisation of Balaxi Pharmaceuticals Ltd(BALAXI) is ₹625.73Cr.

Balaxi Pharmaceuticals Ltd(BALAXIPrice
52 Week High
52 Week Low

Balaxi Pharmaceuticals Ltd(BALAXI) share price is ₹617.4. It is down -10.04% from its 52 Week High price of ₹686.3

Balaxi Pharmaceuticals Ltd(BALAXI) share price is ₹617.4. It is up 54.37% from its 52 Week Low price of ₹399.95

Balaxi Pharmaceuticals Ltd(BALAXIReturns
1 Day Returns
1 Month Returns
3 Month Returns
1 Year Returns